Glomerular Filtration Rate Estimation Using β

cancer patients estimating equations β(2-)microglobulin (B2M) β-trace-protein (BTP) glomerular filtration rate (GFR)

Journal

American journal of kidney diseases : the official journal of the National Kidney Foundation
ISSN: 1523-6838
Titre abrégé: Am J Kidney Dis
Pays: United States
ID NLM: 8110075

Informations de publication

Date de publication:
25 Mar 2024
Historique:
received: 10 08 2023
revised: 06 12 2023
accepted: 02 01 2024
medline: 28 3 2024
pubmed: 28 3 2024
entrez: 27 3 2024
Statut: aheadofprint

Résumé

β Cross-sectional analysis. Prospective cohort of 1,200 patients with active solid tumors recruited between April 2015 and September 2017. CKD-EPI equations without race combining B2M and/or BTP with creatinine with or without cystatin C (2-, 3- or 4-marker panel eGFR). Performance of equations compared to eGFR Bias was defined as the median of the differences between mGFR and eGFR. 1-P Mean (SD) age and mGFR were 58.8 (13.2) years and 78.4 (21.7) ml/min/1.73 m Participants may have had better clinical performance status than the general population of patients with solid tumors. B2M and BTP can improve the accuracy of eGFR and may be useful as confirmatory tests in patients with solid tumors, either by inclusion in multi-marker panel equation with creatinine and cystatin C, or by substituting for cystatin C in combination with creatinine.

Identifiants

pubmed: 38537905
pii: S0272-6386(24)00684-X
doi: 10.1053/j.ajkd.2024.01.532
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Verônica T Costa E Silva (VT)

Serviço de Nefrologia, Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, BR; LIM 16, Serviço de Geriatria, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, BR. Electronic address: veronica.torres@hc.fm.usp.br.

Luiz A Gil (LA)

LIM 66, Serviço de Geriatria, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, BR.

Lesley A Inker (LA)

Division of Nephrology, Tufts Medical Center, Boston, Massachusetts, United States of America.

Renato A Caires (RA)

Serviço de Nefrologia, Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, BR.

Elerson Costalonga (E)

Serviço de Nefrologia, Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, BR.

George Coura-Filho (G)

Serviço de Medicina Nuclear, Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, BR.

Marcelo T Sapienza (MT)

Radiology and Oncology Department, Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, BR.

Gilberto Castro (G)

Serviço de Oncologia Clínica, Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, BR.

Maria Dp Estevez-Diz (MD)

Serviço de Oncologia Clínica, Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, BR.

Dirce Maria T Zanetta (DMT)

Department of Epidemiology, School of Public Health, University of São Paulo, São Paulo, SP, BR.

Leila Antonângelo (L)

LIM 03, Division of Clinical Pathology, University of São Paulo Medical School, São Paulo, SP, BR.

Lia Marçal (L)

LIM 03, Division of Clinical Pathology, University of São Paulo Medical School, São Paulo, SP, BR.

Hocine Tighiouart (H)

Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts, Tufts Clinical and Translational Science Institute, Tufts University, Boston, Massachusetts, United States of America.

Shiyuan Miao (S)

Division of Nephrology, Tufts Medical Center, Boston, Massachusetts, United States of America.

Paul Mathew (P)

Division of Hematology-Oncology, Tufts Medical Center, Boston, Massachusetts, United States of America.

Andrew S Levey (AS)

Division of Nephrology, Tufts Medical Center, Boston, Massachusetts, United States of America.

Emmanuel A Burdmann (EA)

LIM 12, Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, BR.

Classifications MeSH